Gastritis and Gastroduodenitis

Gastritis and gastroduodenitis are common gastrointestinal disorders characterized by inflammation of the gastric mucosa and duodenal lining, respectively. These conditions can range from mild irritation to severe, ulcerative forms, impacting quality of life and overall health. Gastritis, often triggered by factors such as Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs (NSAIDs), and alcohol consumption, leads to symptoms such as nausea, vomiting, and epigastric pain. Gastroduodenitis, a related condition, involves inflammation extending from the stomach to the duodenum and is frequently linked to the same etiological factors. Both disorders share overlapping symptoms, including dyspepsia and bloating, and often coexist. Diagnosing these conditions requires a thorough clinical evaluation, with upper endoscopy being the gold standard for visualizing mucosal damage. Treatment strategies address the underlying causes, such as eradicating H. pylori infection with antibiotics, or modifying lifestyle factors like diet and NSAID use. Proton pump inhibitors (PPIs) and antacids remain key in symptom management, while stress reduction techniques are also encouraged for holistic management. Preventive measures include avoiding irritants, maintaining a balanced diet, and managing stress effectively. Although gastritis and gastroduodenitis are common and often manageable, long-term complications such as gastric ulcers, bleeding, and increased risk of gastric cancer may arise, particularly when the conditions remain untreated or are poorly managed. Early intervention and adherence to treatment regimens are crucial for improving outcomes and preventing further gastrointestinal damage.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-08
DOI
https://doi.org/10.5281/zenodo.14992295
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gastritis and Gastroduodenitis

Zenodo (CERN European Organization for Nuclear Research)
Helicobacter pylori-related gastroenterology studies
article

Gastritis and Gastroduodenitis

article en

Abstract

Gastritis and gastroduodenitis are common gastrointestinal disorders characterized by inflammation of the gastric mucosa and duodenal lining, respectively. These conditions can range from mild irritation to severe, ulcerative forms, impacting quality of life and overall health. Gastritis, often triggered by factors such as Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs (NSAIDs), and alcohol consumption, leads to symptoms such as nausea, vomiting, and epigastric pain. Gastroduodenitis, a related condition, involves inflammation extending from the stomach to the duodenum and is frequently linked to the same etiological factors. Both disorders share overlapping symptoms, including dyspepsia and bloating, and often coexist. Diagnosing these conditions requires a thorough clinical evaluation, with upper endoscopy being the gold standard for visualizing mucosal damage. Treatment strategies address the underlying causes, such as eradicating H. pylori infection with antibiotics, or modifying lifestyle factors like diet and NSAID use. Proton pump inhibitors (PPIs) and antacids remain key in symptom management, while stress reduction techniques are also encouraged for holistic management. Preventive measures include avoiding irritants, maintaining a balanced diet, and managing stress effectively. Although gastritis and gastroduodenitis are common and often manageable, long-term complications such as gastric ulcers, bleeding, and increased risk of gastric cancer may arise, particularly when the conditions remain untreated or are poorly managed. Early intervention and adherence to treatment regimens are crucial for improving outcomes and preventing further gastrointestinal damage.

Zenodo (CERN European Organization for Nuclear Research)
Osh State University (KG)
Good health and well-being
Openalex Percentile: Top 37%
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.